These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 26022363)
21. Narrowband ultraviolet B phototherapy in combination with other therapies for vitiligo: mechanisms and efficacies. Yazdani Abyaneh M; Griffith RD; Falto-Aizpurua L; Nouri K J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1610-22. PubMed ID: 25073648 [TBL] [Abstract][Full Text] [Related]
22. Vitiligo Treatments: Review of Current Therapeutic Modalities and JAK Inhibitors. Cunningham KN; Rosmarin D Am J Clin Dermatol; 2023 Mar; 24(2):165-186. PubMed ID: 36715849 [TBL] [Abstract][Full Text] [Related]
23. Update on childhood vitiligo. Silverberg NB Curr Opin Pediatr; 2010 Aug; 22(4):445-52. PubMed ID: 20616733 [TBL] [Abstract][Full Text] [Related]
31. Why treatments do(n't) work in vitiligo: An autoinflammatory perspective. Speeckaert R; Speeckaert MM; van Geel N Autoimmun Rev; 2015 Apr; 14(4):332-40. PubMed ID: 25500433 [TBL] [Abstract][Full Text] [Related]
32. The effectiveness of therapeutic interventions on quality of life for vitiligo patients: a systematic review. Chan MF; Chua TL Int J Nurs Pract; 2012 Aug; 18(4):396-405. PubMed ID: 22845640 [TBL] [Abstract][Full Text] [Related]
33. Treatment of vitiligo: advantages and disadvantages, indications for use and outcomes. Hossani-Madani A; Halder R G Ital Dermatol Venereol; 2011 Oct; 146(5):373-95. PubMed ID: 21956273 [TBL] [Abstract][Full Text] [Related]
34. Childhood facial vitiligo: how intractable is it? Kim SA; Cho S; Kwon SH; Park JT; Na JI; Huh CH; Park KC J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):713-8. PubMed ID: 25174801 [TBL] [Abstract][Full Text] [Related]
35. Effect of narrow band ultraviolet B phototherapy as monotherapy or combination therapy for vitiligo: a meta-analysis. Li R; Qiao M; Wang X; Zhao X; Sun Q Photodermatol Photoimmunol Photomed; 2017 Jan; 33(1):22-31. PubMed ID: 27696531 [TBL] [Abstract][Full Text] [Related]
36. Camouflaging Agents for Vitiligo Patients. Hossain C; Porto DA; Hamzavi I; Lim HW J Drugs Dermatol; 2016 Apr; 15(4):384-7. PubMed ID: 27050692 [TBL] [Abstract][Full Text] [Related]
37. Vitiligo treatment in childhood: a state of the art review. Tamesis ME; Morelli JG Pediatr Dermatol; 2010; 27(5):437-45. PubMed ID: 20553403 [TBL] [Abstract][Full Text] [Related]
38. Pediatric vitiligo. Silverberg NB Pediatr Clin North Am; 2014 Apr; 61(2):347-66. PubMed ID: 24636650 [TBL] [Abstract][Full Text] [Related]
39. Current state of vitiligo therapy--evidence-based analysis of the literature. Forschner T; Buchholtz S; Stockfleth E J Dtsch Dermatol Ges; 2007 Jun; 5(6):467-75. PubMed ID: 17537039 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of an oral supplement containing Phyllanthus emblica fruit extracts, vitamin E, and carotenoids in vitiligo treatment. Colucci R; Dragoni F; Conti R; Pisaneschi L; Lazzeri L; Moretti S Dermatol Ther; 2015; 28(1):17-21. PubMed ID: 25285994 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]